Vericel (VCEL) Misses Q4 EPS by 5c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. LRCX
6. LVS
7. SAP
8. CSX
9. QGEN
10. KNX

Go back to Vericel (VCEL) Misses Q4 EPS by 5c

Vericel Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Full-Year 2022 Financial Guidance

February 24, 2022 7:55 AM EST

Full-Year 2021 Total Revenue Growth of 26%

Full-Year 2022 Total Revenue Guidance of $178 to $189 Million

Conference Call Today at 8:30am Eastern Time

CAMBRIDGE, Mass., Feb. 24, 2022 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ: VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today reported financial results and business highlights for the fourth quarter and year ended December 31, 2021, and provided full-year 2022 financial guidance.

Fourth Quarter 2021 Financial Highlights

Total net revenue of $47.6... More